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Brief CommunicationsThe loss of cyclooxygenase in platelets, which lack the capacity
for new protein synthesis, constitutes a loss of function for the
remainder of their lifetime. The average life span of platelets is 7
days; therefore the conventional practice is to stop aspirin therapy
1 week before the planned procedure. However, the results of this
study show that inhibition of platelet aggregation with aspirin
vanishes earlier than expected. The life span of the platelet and
platelet aggregation as a whole need to be understood separately.
Although it may take 10 days for the total platelet population to be
renewed and thus restore normal cyclooxygenase activity, it has
been shown in vitro that if as few as 20% of total platelets have
normal cyclooxygenase activity, aggregation would remain nor-
mal.5 Our study has confirmed this finding in the clinical situation.
This study has several limitations. One of these is the small
study population. We therefore should extend this study and in-
vestigate the outcomes. Another limitation concerns aspirin dos-
ages, which were low (81 mg/d) in this study. If the aspirin dosage
had been higher, the speed of recovery of aggregation might have
been different.
In conclusion, this study indicates that inhibition of plateletJean-Franc¸ois Bonneville, MD, and Joseph-Philippe Etievent, M
The Journal of Thoracication and vanished after 3 days. Therefore, in the presence of
preoperative aspirin therapy, stopping at 3 days before surgery
might be optimal for preventing bleeding complications. In addi-
tion, this study result should be considered when comparing aspi-
rin users versus nonusers in future investigations into the effects of
aspirin in cardiac surgery.
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Surgical pitfalls during explantation of a thoracic aortic
endoprosthesis
Lucian Stoica, MD, PhD,a Sidney Chocron, MD, PhD,a Pierre-Emmanuel Falcoz, MD,a
b aD, Besanc¸on, FranceWe report our experience with explantation of athoracic aortic endoprosthesis 2 years after theinitial procedure. This graft was explanted be-cause of failure of endovascular treatment of an
aneurysm that developed after surgical treatment of a type A aortic
dissection. Crossclamping of the aortic arch was impossible, and
surgery had to be performed with the patient under circulatory
arrest. The procedures performed are time-consuming under cir-
culatory arrest, making distal aortic arch surgery more complex
after endovascular repair than when performed at primary surgery.
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doi:10.1016/j.jtcvs.2003.12.026Clinical Summary
A 48-year-old man was operated on
for acute type-A aortic dissection.
We performed a supracoronary graft
replacement of the ascending aorta
under hypothermic circulatory arrest
with cerebral retroperfusion through
the superior vena cava.1 We found
only one intimal tear on the ascending aorta. The aortic valve was
spared. One year later, magnetic resonance imaging control re-
vealed a perfused false lumen with dilatation of the aorta to 53
mm. Aortography showed a communication between the two lu-
mens just below the origin of the left subclavian artery. A Talent
endoluminal stent graft (World Medical Corp, Sunrise, Fla) was
deployed 17 months after the first operation. It covered the origin of
the left subclavian artery, and the uncovered part was placed facing
the origin of the left common carotid artery. Because the false lumen
was still being perfused by the left subclavian artery, the origin of the
artery was completely obstructed with coils (Figure 1). The treatment
was completed with a bypass between the left carotid artery and the
left subclavian artery to avoid left arm ischemia.
Two years after endovascular treatment, the false lumen was
still perfused and the diameter of the postisthmic thoracic aorta had
increased to 57 mm (Figure 1). We performed the explantation of
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Brief Communicationsunder hypothermic circulatory arrest, and we replaced the proxi-
mal part of the descending aorta with a Dacron polyester fabric
graft. Left femoral vein cannulation was impossible, so the pul-
monary artery trunk was cannulated to drain the venous blood. The
arterial blood was injected into the left femoral artery. Cerebro-
spinal fluid drainage was used to enhance medullar protection.2
While opening the false lumen longitudinally, we found that the
aortic stent did not adhere to the aortic wall in the Dacron graft–
covered part; rather, the two extremities not covered were deeply
embedded in the aortic media and hampered stent extraction. We
also found a large communication between the two channels at the
level of the proximal uncovered part of the stent (Figure 2).
Finally, the aortic arch was not dissected, and the aneurysm started
at the level of the left subclavian artery, the origin of which was
totally thrombosed.
A 30-mm Dacron polyester fabric graft was inserted from the
heel of the left common carotid artery down to the sixth dorsal
Figure 1. False lumen is still perfused after endovascul
stent-graft deployment (B), and computed tomographic
aorta developed life-threatening aneurysm.
Figure 2. A, Cannula passes through communication be
graft. B, Endoprosthesis inside true lumen.vertebra level. Distally, the graft anastomosis reimplanted both
1816 The Journal of Thoracic and Cardiovascular Surgery ● Junchannels. The patient was doing well 10 months after this opera-
tion.
Discussion
In our experience, surgery of the distal aortic arch and proximal
descending aorta is more difficult after endovascular treatment
than when performed in primary surgery. Crossclamping of the
aortic arch in this case was impossible because the uncovered part
of the endoprosthesis was placed inside the aortic arch, facing the
left carotid artery ostia. This meant that surgery had to be done
with the patient under circulatory arrest.
The explantation of the endoprosthesis was difficult. The graft
became embedded in the media of the aortic wall, so we had to be
cautious when extracting the two extremities of the endoprosthesis.
There were only a few centimeters of aortic arch between the distal
suture of the ascending aorta Dacron polyester fabric graft and the
proximal extremity of the endoprosthesis. Because of the high risk
atment. Arteriography of initial aneurysm (A) and after
20 months after endovascular treatment (C). Thoracic
n false lumen (arrow) and true lumen containing stentar tre
scantweee 2004
Brief Communicationsof aortic arch rupture, we could not remove the covered portion of
the endoprosthesis by pulling it. We had to cut and remove each
branch separately, which extended the duration of circulatory
arrest significantly. The proximal suture of the arch reconstruction
was difficult to perform because of fibrosis of the tissues.
In our case femoral vein cannulation was impossible; the can-
nula stopped in the iliac vein with the patient in the left thoracot-
omy position as well as the dorsal decubitus position. A good
venous return is needed for circulatory arrest, so we cannulated the
pulmonary artery trunk This kind of cannulation entails consider-
able risk because of the fragility of the tissue, and the pulmonary
artery may be torn when cannulated. Moreover, occluding the
cannula to avoid leakage of blood is difficult.
We found a large communication between the two channels
facing the proximal uncovered part of the stent. We do not know
whether this communication existed before or was caused by the
insertion of the stent, but it was the cause of failed endovascular
treatment in our case. We did not use a balloon to expand the stent
when deploying the endoprosthesis to avoid any risk of creating a
communication between the two channels.
These findings suggest the difficulties associated with the en-Jeffrey A. Morgan, MD, Ranjit John, MD, Donna M. Mancini, M
The Journal of Thoracicreentry points between the two lumina may be found on the
descending thoracic aorta, making endovascular treatment hazard-
ous. If secondary surgery is required, the repair is more difficult
than it is in primary surgery because aortic crossclamping is
impossible. Therefore the explantation of the endoprosthesis and
the reconstruction of the aortic arch must be done under circulatory
arrest. The explantation of the stent graft is also technically diffi-
cult, because it is deeply embedded in the aortic wall.
We thank Nancy Richardson-Peuteuil for her editorial assis-
tance.
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Should heart transplantation be considered as a treatment option for
patients aged 70 years and older?D, and Niloo M. Edwards, MD, New York, NYSeveral studies have demonstrated favorable results afterorthotopic cardiac transplantation in recipients of ad-vanced age.1-4 These studies have demonstrated similarsurvival in elderly patients as compared to that of
younger patients undergoing heart transplantation. This has re-
sulted in a relaxation of the upper age limit for cardiac transplan-
tation in many centers. However, some transplant centers continue
to view advanced recipient age as a contraindication to transplan-
tation because of concerns regarding decreased survival in this
cohort.5-7 This study was conducted to analyze and compare our
experiences with older (70 years and older) versus younger
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doi:10.1016/j.jtcvs.2003.12.035(younger than 70 years) recipients with respect to perioperative
and long-term survivals.
Patients and Methods
Between January 1992 and February 2003, a total of 939 ortho-
topic cardiac transplants were performed at the New York Pres-
byterian Hospital–Columbia Medical Center, New York. Of these,
10 (1.1%) were performed in patients 70 years old or older (range
70.2-74.8 years). These patients were compared with patients
younger than 70 years (range 18.3-69.8 years) at the time of
transplantation. Pediatric patients (younger than 18 years; n 
115) were excluded. Outcome measures included perioperative
and long-term posttransplantation survivals.
Statistical analysis. Data were represented as frequency dis-
tributions and percentages. Values of continuous variables were
expressed as mean  SD. Continuous variables were compared
with paired t tests, whereas categorical variables were compared
by means of 2 tests. Kaplan-Meier analysis was used to calculate
survival along with a log-rank P value when comparing groups.
Actuarial survivals at 1, 3, 5, and 10 years after transplantation
were calculated by constructing life tables. Significant predictors
of mortality were identified with multivariate Cox proportional
hazard models. All data were analyzed with the SPSS 11.5 soft-
ware package (SPSS Inc, Chicago, Ill).
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